-+ 0.00%
-+ 0.00%
-+ 0.00%

CAN FITE BIOPHARMA - CAN-FITE SUBMITS PHASE 2 STUDY PROTOCOL FOR PICLIDENOSON IN LOWE SYNDROME

Reuters·08/03/2026 11:05:00

Please log in to view news